c-KIT expands the tool kit for treating arteriovenous malformation

J Clin Invest. 2026 Oct 1;136(19):e210364. doi: 10.1172/JCI210364. eCollection 2026 Oct 1.ABSTRACTHereditary hemorrhagic telangiectasia (HHT) is characterized by fragile, enlarged vessels with arteriovenous connections, which can form arteriovenous malformations (AVMs) that are prone to rupture. It

R Ruilin Wu

Unilateral Pulmonary Artery Lesion in an Immunocompromised Patient

Respirol Case Rep. 2026 Sep 30;14(10):e70778. doi: 10.1002/rcr2.70778. eCollection 2026 Oct.ABSTRACTWe report a 62-year-old man with myelodysplastic syndrome on immunosuppressive therapy who presented with right lung consolidation and neutropenia. Despite broad antimicrobial therapy for presumed pne

S Seunghoon Lee

Risk of Progression and Costs of Care for Patients With Chronic Kidney Disease

Kidney Med. 2026 Aug 3;8(10):101484. doi: 10.1016/j.xkme.2026.101484. eCollection 2026 Oct.ABSTRACTRATIONALE & OBJECTIVE: Chronic kidney disease (CKD) is associated with substantial economic burden. Early identification of high-risk patients with CKD can facilitate timely intervention and reduce CKD

N Navdeep Tangri

Hypertriglyceridemia: Causes, Consequences, Diagnosis, and Management

MedComm (2020). 2026 Sep 30;7(10):e70956. doi: 10.1002/mco2.70956. eCollection 2026 Oct.ABSTRACTManaging hypertriglyceridemia (HTG) requires more than lowering triglyceride (TG) levels. Two related but clinically distinct risk domains often guide management: residual atherosclerotic cardiovascular d

S Shanshan Qi

Rare-Earth Nanomaterials for Advanced Theranostics of Atherosclerosis

Chem Biomed Imaging. 2026 Apr 21;4(9):1933-1961. doi: 10.1021/cbmi.5c00284. eCollection 2026 Sep 28.ABSTRACTAtherosclerosis (AS) poses major challenges for precise diagnosis and targeted therapy due to its complex inflammatory and oxidative plaque microenvironment. This review begins by dissecting t

Q Qianqian Bai